Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

11.25
Delayed Data
As of Feb 17
 -0.05 / -0.44%
Today’s Change
6.00
Today|||52-Week Range
13.45
-7.41%
Year-to-Date

Today’s Trading

Previous close11.30
Today’s open11.90
Day’s range10.55 - 11.94
Volume354,167
Average volume (3 months)306,775
Market cap$455.8M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-620.51%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+271.30%
P/E ratioNM
Price/Sales4.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NLNKNewLink Genetics Cor...+0.31+2.07%
LBIOLion Biotechnologies...-0.02-0.35%
OTICOtonomy Inc+0.50+3.32%
OMEROmeros Corp-0.07-0.63%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)-$0.52
Annual revenue (last year)$106.4M
Annual profit (last year)$16.5M
Net profit margin15.46%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Barabari Sharon A. Surrey
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs